Clearside Biomedical reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Clearside Biomedical using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-12 | $-0.10 | $-0.13 | 23.1 % |
Q2 | 2024-08-12 | $-0.10 | $-0.13 | 23.1 % |
Q1 | 2024-05-09 | $-0.17 | $-0.14 | -21.4 % |
Q4 | 2024-03-12 | $-0.08 | $-0.09 | 11.1 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-12 | $1.04M | $122.86K | 744.9 % |
Q2 | 2024-08-12 | $90.00K | $150.00K | -40.0 % |
Q1 | 2024-05-09 | $230.00K | $580.00K | -60.3 % |
Q4 | 2024-03-12 | $6.35M | $4.43M | 43.2 % |
Clearside Biomedical (CLSD) is scheduled to report earnings on March 11, 2025. The last reported earnings were for reported on November 12, 2024 for Q3.
The Actual EPS was $-0.10, which beat the estimate of $-0.13.
The Actual Revenue was $1M, which beat the estimate of $122.9K.
Browse earnings estimates, EPS, and revenue on all stocks.